Search results
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
St. Louis Post-Dispatch· 6 days agoDoctors also expect some patients will hesitate to take Leqembi due to its limited impact and...
NYU Langone Health's New Optimal Aging Institute to Further Explore the Link Between Vascular Health...
WLNS Lansing· 2 weeks agoInstitute at NYU Langone Health have been awarded $31 million by the National Institutes of Health (NIH) for a diverse, ten university cohort to study how vascular risk factors contribute to ...